Quick answerOptions 2, 3, and 1: age-preferred influenza vaccine, second zoster dose, and one RSV dose.
Why this is correctAdults 65 and older should preferentially receive high-dose, adjuvanted, or recombinant influenza vaccine each season. The recombinant zoster series is 2 doses 2 to 6 months apart, but a late second dose is simply given; the series is never restarted. RSV vaccine is recommended as a single lifetime dose for adults 75 and older and for adults 60 to 74 at increased risk, and COPD is a qualifying chronic lung condition.
Easy analogy or mental pictureA vaccine record is like a punch card: a late punch still counts, a completed card needs no more punches, and a punch not due yet waits.
Memory hookLate dose? Continue, don't restart. PCV20 = done. Tdap clock = 10 years.
NCLEX decision ruleFor immunization items, calculate each vaccine from the dates in the stem (interval, age, risk condition) rather than listing every vaccine an older adult could receive.
Why the other choices are wrongRestarting the zoster series (option 6): tempting because the 2-to-6-month interval was exceeded, but CDC advises giving the second dose without restarting. PPSV23 (option 5): tempting because it used to follow PCV13 or PCV15, but PCV20 alone completes the series for this age group. Td/Tdap booster (option 4): tempting because tetanus protection is routine, but the last dose was 9 years ago, so the 10-year booster is not yet due in the absence of a wound.
References
1CDC Adult Immunization Schedule by AgeInfluenza, pneumococcal, Td/Tdap, and zoster recommendations for adults 65 and older
2CDC RSV Vaccine Guidance for Older AdultsSingle RSV dose for adults 60-74 at increased risk, including chronic lung disease
3CDC Shingles Vaccine Clinical ConsiderationsIf more than 6 months have passed, give the second RZV dose; do not restart the series